| TA116 |
Breast cancer - gemcitabine (TA116) |
|
-
-
advanced breast cancer
Fast, easy summary view of NICE guidance on 'advanced breast cancer'
-
-
-
Gemcitabine for the treatment of metastatic breast cancer
Gemcitabine, which is combined with another medicine called paclitaxel to treat metastatic breast cancer, is only recommended as a possible treatment for people with metastatic breast cancer in situations where two other treatments could also be used as alternatives.
Other treatments that doctors could use in the same situation are a medicine called docetaxel (given on its own) and docetaxel combined with another medicine called capecitabine.
-
Other information
NICE Pathways
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: advanced breast cancer
How this guidance was produced
Background information
This page was last updated: 26 October 2011
-
-
Guidance formats
-
Patient
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
NICE Guidance
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
Full Guidance
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.
